Pharmaniaga Berhad (Pharmaniaga) is a

Malaysia Malaysia ( ; ) is a country in Southeast Asia. The federation, federal constitutional monarchy consists of States and federal territories of Malaysia, thirteen states and three federal territories, separated by the South China Sea into two r ...

pharmaceutical A medication (also called medicament, medicine, pharmaceutical drug, medicinal drug or simply drug) is a drug used to diagnose, cure, treat, or prevent disease. Drug therapy (pharmacotherapy) is an important part of the medical field and re ...

company. It is a subsidiary of

Boustead Holdings Boustead Holdings Berhad (BHB) () is a Malaysian corporation with over 16,000 employees across more than 80 listed and non-listed companies in Malaysia, Indonesia and the United Kingdom. It is an affiliate of the Malaysian military. BHB was foun ...

, an affiliate of the Malaysian military.

History

Pharmaniaga was established in 1994 as ''Remedi Pharmaceuticals''. The company was renamed as ''Pharmaniaga'' in August 1998 and is the first healthcare company in Malaysia to be listed in the Main Market of Kuala Lumpur Stock Exchange (now

Bursa Malaysia Bursa Malaysia is the stock exchange of Malaysia. It is one of the largest bourses in ASEAN. It is based in Kuala Lumpur and was previously known as the Kuala Lumpur Stock Exchange (KLSE). It provides a full integration of transactions, offeri ...

).Pharmaniaga Berhad: An analysis
UK Essay (April 5, 2017). Retrieved on April 5, 2017.

Ownership

Pharmaniaga is a public limited company. Its two major shareholders are

and

Lembaga Tabung Angkatan Tentera The Armed Forces Fund Board (also commonly known by its Malay name Lembaga Tabung Angkatan Tentera and LTAT in short) is a statutory body which manages the pension fund for certain members of the Malaysian Armed Forces. LTAT was established in Au ...

(LTAT). The major owner of Boustead Holdings is itself LTAT. The Company's Board Members comprise Izaddeen Daud, Non-Independent Non-Executive Chairman, Dr Abdul Razak Ahmad, Senior Independent Non-Executive Director, YB Senator Datuk Dr. Haji Azhar Ahmad, Sarah Azreen Abdul Samat, Datuk Lim Thean Shiang and Dr Mary Jane Cardosa as Independent Non-Executive Directors, while Ahmad Shahredzuan Mohd Shariff is a Non-Independent Non-Executive Director. On 14 March, Pharmaniaga has formed an executive committee (EXCO) in the interim, comprising Ahmad Shahredzuan Mohd Shariff, Non-independent Non-Executive Director; Zulkifli Jafar, Deputy Chief Executive Officer; Mohamed Iqbal Abdul Rahman, Chief Operating Officer and Norai'ni Mohamed Ali, Chief Financial Officer.

Business Overview

Pharmaniaga is involved in various segments of the pharmaceutical value chain, including research and development, manufacturing of generic drugs and medical devices, logistics and distribution, sales and marketing, as well as community pharmacy. Pharmaniaga has over 3,600 employees, and more than 300 scientists, including researchers, chemists, pharmacologists, formulators, IT engineers, regulatory and clinical affairs specialists. With eight manufacturing plants, Pharmaniaga is capable of producing products in various forms; from oral solids, liquids and creams to small volume injectables. Its product portfolio encompasses a diverse segment of therapeutic areas such as cardiovascular, anti-diabetic, antibiotics, antivirals, over the counter products and nutraceuticals, amongst others. Its Indonesia operations include two manufacturing plants and a public listed pharmaceutical logistics and distribution company with 33 branches throughout the republic.

References

{{authority control Government-owned companies of Malaysia Companies listed on Bursa Malaysia Pharmaceutical companies of Malaysia Pharmaceutical companies established in 1994 Companies based in Shah Alam 1994 establishments in Malaysia Malaysian brands